Vectors Research Management’s Edwards Lifesciences EW Stock Holding History

Vectors Research Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-27	Closed	-$2K	–	449
2020 Q3	$2K	Sell	27 -90	-77%	-$7.02K	﹤0.01%	382
2020 Q2	$8K	Hold	117	–	–	﹤0.01%	313
2020 Q1	$7K	Hold	117	–	–	﹤0.01%	330
2019 Q4	$9K	Buy	117 +90	+333%	+$7.03K	﹤0.01%	361
2019 Q3	$2K	Hold	27	–	–	﹤0.01%	428
2019 Q2	$2K	Hold	27	–	–	﹤0.01%	385
2019 Q1	$2K	Buy	+27	New	+$1.54K	﹤0.01%	381
2018 Q4	–	Sell	-27	Closed	-$1K	–	683
2018 Q3	$1K	Buy	+27	New	+$1.32K	﹤0.01%	462

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vectors Research Management's EW Position: Q4 2020 in Review

Vectors Research Management sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 27 shares — an estimated $2K sold.

Vectors Research Management first reported a position in EW in Q3 2018 and held it in 8 quarters. The position peaked at $9K in Q4 2019. 1,158 funds tracked by Wall St. Rank hold EW as of Q4 2020.

Vectors Research Management reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
Vectors Research Management sold 27 Edwards Lifesciences shares in Q4 2020, an estimated $2K.
Vectors Research Management first reported a position in Edwards Lifesciences in Q3 2018 and held it in 8 quarters.
Vectors Research Management's Edwards Lifesciences position peaked at $9K in Q4 2019.
1,158 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Vectors Research Management's 13F filing for Q4 2020, filed 9 Feb 2021.